These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

83 related items for PubMed ID: 111380

  • 1. Cytotoxic and agglutinating H-Y antibodies in multiparous female mice.
    Krupen-Brown K, Wachtel SS.
    Transplantation; 1979 Jun; 27(6):406-9. PubMed ID: 111380
    [Abstract] [Full Text] [Related]

  • 2. Non-H-2 histocompatibility antigens encoded by Moloney-murine leukemia virus in Mov mouse strains are detectable by skin grafting and cytolytic T lymphocytes.
    Wettstein PJ, Colombo MP, Jaenisch R.
    J Immunol; 1988 Jun 15; 140(12):4337-41. PubMed ID: 3286772
    [Abstract] [Full Text] [Related]

  • 3. T lymphocyte responses to multiple minor histocompatibility antigens generate both self-major histocompatibility complex-restricted and cross-reactive cytotoxic T lymphocytes.
    Tremblay N, Fontaine P, Perreault C.
    Transplantation; 1994 Jul 15; 58(1):59-67. PubMed ID: 8036709
    [Abstract] [Full Text] [Related]

  • 4. The role of anti-H-2K and H-2D alloantibodies in enhancement and acute antibody-mediated rejection of mouse skin allografts.
    de Waal RM, Capel PJ, Koene RA.
    J Immunol; 1980 Feb 15; 124(2):719-23. PubMed ID: 6985936
    [Abstract] [Full Text] [Related]

  • 5. Specific tolerance induction of allo-K(b)-skin grafts by FK506 in the CD8-depleted H-2(k) recipients required low amounts of K(b)-antigen.
    Chen BG, Liu Z, Wu Y.
    Transpl Immunol; 2005 Oct 15; 15(1):9-16. PubMed ID: 16223668
    [Abstract] [Full Text] [Related]

  • 6. Carcinogen-treated skin allografts rejected by T lymphocytes specific for class I but not class II MHC antigens.
    Halliday GM, Odling KA, Muller HK.
    Cell Immunol; 1993 Oct 15; 151(2):291-9. PubMed ID: 8402936
    [Abstract] [Full Text] [Related]

  • 7. Keratinocytes synthesize Ia antigen in acute cutaneous graft-vs-host disease.
    Breathnach SM, Katz SI.
    J Immunol; 1983 Dec 15; 131(6):2741-5. PubMed ID: 6417231
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Split tolerance to the MHC class I molecule H-2Dd in animals transgenic for its soluble analog.
    Hunziker RD, Lynch F, Shevach EM, Margulies DH.
    Hum Immunol; 1997 Feb 15; 52(2):82-94. PubMed ID: 9077557
    [Abstract] [Full Text] [Related]

  • 10. H-Y status of X/X Sxr' male mice: in vivo tests.
    Simpson E, Chandler P, Hunt R, Hogg H, Tomonari K, McLaren A.
    Immunology; 1986 Mar 15; 57(3):345-9. PubMed ID: 3514439
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Allograft rejection by T cell receptor transgenic mice.
    Bassiri H, Markmann JF, Desai NM, Kim JI, Teh HS, Barker CF.
    J Surg Res; 1993 May 15; 54(5):437-44. PubMed ID: 8361170
    [Abstract] [Full Text] [Related]

  • 13. Ia versus K/D antigens in immunological enhancement of tumour allografts. II. Studies with alloimmune sera prepared in recombinant strains.
    Duc HT, Kinsky RG, Voisin GA.
    Ann Immunol (Paris); 1979 May 15; 130C(3):461-74. PubMed ID: 475347
    [Abstract] [Full Text] [Related]

  • 14. H-Y antigen as a model for tumor antigens: the role of H-2-associative antigens in controlling anti-H-Y immune responses.
    Simpson E, Matsunaga T, Brenan M, Brunner C, Benjamin D, Hetherington C, Hurme M, Chandler P.
    Transplant Proc; 1980 Mar 15; 12(1):103-6. PubMed ID: 6768177
    [No Abstract] [Full Text] [Related]

  • 15. Regulation of transplantation immunity in vivo by monoclonal antibodies recognizing host class II restriction elements. I. Genetics and specificity of anti-Ia immunotherapy in murine skin allograft recipients.
    Perry LL, Williams IR.
    J Immunol; 1985 May 15; 134(5):2935-41. PubMed ID: 2580008
    [Abstract] [Full Text] [Related]

  • 16. An investigation of allograft tolerance: Discordant reactivity to murine H-Y-incompatible lymphoid cell (PEC) and skin grafts.
    Haughton G, Daly JA, Wikstrand CJ.
    Transplantation; 1979 Mar 15; 27(3):203-7. PubMed ID: 107632
    [Abstract] [Full Text] [Related]

  • 17. Non-H-2-linked genetic regulation of cytotoxic responses to hapten-modified syngeneic cells. I. Non-H-2-linked Ir gene defect expressed on T cells is not predetermined at the stage of bone marrow cells.
    Ogata M, Shimizu J, Tsuchida T, Takai Y, Fujiwara H, Hamaoka T.
    J Immunol; 1986 Feb 15; 136(4):1178-85. PubMed ID: 2935573
    [Abstract] [Full Text] [Related]

  • 18. Reduced diversity of CTLs specific for multiple minor histocompatibility antigens relative to allograft rejection in vivo.
    Nevala WK, Paul C, Wettstein PJ.
    J Immunol; 1997 Feb 01; 158(3):1102-7. PubMed ID: 9013948
    [Abstract] [Full Text] [Related]

  • 19. The replacement of graft endothelium by recipient-type cells conditions allograft rejection mediated by indirect pathway CD4+ T cells.
    Kapessidou Y, Habran C, Buonocore S, Flamand V, Barvais L, Goldman M, Braun MY.
    Transplantation; 2006 Aug 27; 82(4):582-91. PubMed ID: 16958183
    [Abstract] [Full Text] [Related]

  • 20. Effects of hapten epitope structure and hapten-self conjugation pattern on T cell specificity and Ir gene control in hapten-self cytotoxic and helper T cell responses.
    Takai Y, Mizuochi T, Fujiwara H, Hamaoka T.
    J Immunol; 1984 Jan 27; 132(1):57-62. PubMed ID: 6197460
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.